Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study

James Tollitt, Aghogho Odudu, Emma Flanagan, Rajkumar Chinnadurai, Craig Smith, Philip A Kalra

Research output: Contribution to journalArticlepeer-review


BACKGROUND: Chronic kidney disease (CKD) is an independent risk factor for stroke in the general population. The impact of prior stroke on major clinical outcomes in CKD populations is poorly characterised.

METHODS: The Salford Kidney Study is a UK prospective cohort of more than 3000 patients recruited since 2002 and followed until March 2018. Multivariable Cox regression examined associations of stroke at two time points; cohort inception, and at dialysis initiation, with risks of death, non-fatal cardiovascular events (NFCVE) and end stage renal disease (ESRD).

RESULTS: 277 (9.1%) of 3060 patients suffered a prior stroke and this was associated with mortality, ESRD and future NFCVE after cardiovascular risk factor adjustments. Median survival for prior stroke patients was 40 months vs 77 months in patients without a stroke. Prior stroke was independently associated with mortality (HR 1.20 95%CI 1.0-1.43, p = 0.05). Of 579 patients who reached ESRD and commenced dialysis, a prior stroke (N = 48) was independently associated with mortality. Median survival for the prior stroke group was 29 months compared with 50 months for the non-stroke group. Only 70 and 75% of patients who had suffered an ischaemic stroke were prescribed antiplatelets or statins respectively.

CONCLUSIONS: A diagnosis of stroke is strongly and independently associated with several adverse clinical outcomes for patients with CKD. Prior stroke profoundly alters cardiovascular risk in CKD patients. Greater attention to primary and secondary preventive strategies is warranted which may improve these outcomes.

Original languageEnglish
Pages (from-to)432
JournalBMC Nephrology
Issue number1
Publication statusPublished - 27 Nov 2019


Dive into the research topics of 'Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study'. Together they form a unique fingerprint.

Cite this